National Research (NRC) - Likuiditas cepet

National Research (NRC) provides cloud analytics services for healthcare quality control, leveraging a distributed network of data centers. The historical price action of the quick ratio, which currently stands at 0.63, confirms the issuer's financial stability. Through multi-year contracts with clinics, National Research (NRC) ensures high returns and complete autonomy of its working capital from market volatility.

National Research is optimizing costs by leveraging cloud infrastructure and outsourcing support to concentrate on analytical software. The quick ratio measures the company's ability to meet short-term obligations using cash and accounts receivable, completely excluding illiquid inventories. This metric allows investors to assess the real financial stability of the business under stress. The acid-test ratio trend demonstrates the efficiency of working capital management relative to industry averages.